Biotech

All Articles

Repare lays off 25% of team as biotech standstills preclinical R&ampD

.Repare Therapy is actually giving up a fourth of its workforce as the oncology biotech lessen its o...

J &amp J declare FDA approval of $6.5 B autoimmune drug

.Johnson &amp Johnson has actually gotten one more measure toward realizing a gain on its $6.5 billi...

Gain's stage 1 succeed leads means to show Parkinson's medicine's worth

.Increase Therapies has actually prepared its own sights on confirming the performance of its own Pa...

Actinogen reports new stage 2 records to restore depression medicine

.Actinogen Medical's hopes-- and also inventory price-- have actually recoiled slightly from previou...

Pfizer and Crown jewel include Quotient to multibillion-dollar equation

.Flagship Pioneering as well as Pfizer have actually incorporated Ratio into their 10-program partne...

Bayer markers $547M pact to drive limits of noncoding RNA

.Bayer managers were actually keen to worry to Brutal this summertime that the German pharma titan's...

UK unveils plans to release 18 new clinical test centers

.Amidst a yearslong professional trial decrease in the U.K., a brand-new public-private alliance has...

UPDATE: Genentech telegrams 93 cutbacks in The golden state after discussing strategies to shutter cancer cells immunology study system

.Complying with the announcement of a huge discharge shot in April and a significant restructuring c...

Neurocrine's KarXT opponent hits in phase 2-- but only at reduced dosage

.Neurocrine Biosciences has achieved its own hoped-for account in a phase 2 mental illness test, sup...

Vaderis' unusual capillary problem drug reduces nosebleeds

.Vaderis Therapies' objective to create the 1st medicine targeted exclusively at a specific unusual ...